CoChat

The Search for Natural and Synthetic Inhibitors That Would Complement Antivenoms as Therapeutics for Snakebite Envenoming

Gutiérrez, José María, Albulescu, Laura-Oana, Clare, Rachel H., Casewell, Nicholas R., Abd El-Aziz, Tarek Mohamed, Escalante, Teresa, Rucavado, Alexandra · 2021 · Toxins
Cited by 96

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

A global strategy, under the coordination of the World Health Organization, is being unfolded to reduce the impact of snakebite envenoming. One of the pillars of this strategy is to ensure safe and effective treatments. The mainstay in the therapy of snakebite envenoming is the administration of animal-derived antivenoms. In addition, new therapeutic options are being explored, including recombinant antibodies and natural and synthetic toxin inhibitors. In this review, snake venom toxins are classified in terms of their abundance and toxicity, and priority actions are being proposed in the search for snake venom metalloproteinase (SVMP), phospholipase A2 (PLA2), three-finger toxin (3FTx), and serine proteinase (SVSP) inhibitors. Natural inhibitors include compounds isolated from plants, animal sera, and mast cells, whereas synthetic inhibitors comprise a wide range of molecules of a variable chemical nature. Some of the most promising inhibitors, especially SVMP and PLA2 inhibitors, have been developed for other diseases and are being repurposed for snakebite envenoming. In addition, the search for drugs aimed at controlling endogenous processes generated in the course of envenoming is being pursued. The present review summarizes some of the most promising developments in this field and discusses issues that need to be considered for the effective translation of this knowledge to improve therapies for tackling snakebite envenoming.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/toxins13070451

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 207

  1. Kasturiratne, 2008, The global burden of snakebite: A literature analysis and modelling based on regional estimates of envenoming and deaths, PLoS Med., 5, 1591, 10.1371/journal.pmed.0050218 · DOI · Paper page
  2. Calvete, 2017, Snakebite envenoming, Nat. Rev. Dis. Prim., 3, 17063, 10.1038/nrdp.2017.63 · DOI · Paper page
  3. Harrison, R.A., Hargreaves, A., Wagstaff, S.C., Faragher, B., and Lalloo, D.G. (2009). Snake envenoming: A disease of poverty. PLoS Negl. Trop. Dis., 3. · DOI · Paper page
  4. Chaves, L.F., Chuang, T.W., Sasa, M., and Gutiérrez, J.M. (2015). Snakebites are associated with poverty, weather fluctuations, and El Niño. Sci. Adv., 1. · DOI
  5. Hotez, 2009, Rescuing the bottom billion through control of neglected tropical diseases, Lancet, 373, 1570, 10.1016/S0140-6736(09)60233-6 · DOI · Paper page
  6. Molyneux, 2016, The London Declaration on Neglected Tropical Diseases: 5 years on, Trans. R. Soc. Trop. Med. Hyg., 110, 623
  7. Theakston, 2006, Confronting the neglected problem of snake bite envenoming: The need for a global partnership, PLoS Med., 3, 0727
  8. Gutiérrez, J.M., Warrell, D.A., Williams, D.J., Jensen, S., Brown, N., Calvete, J.J., and Harrison, R.A. (2013). The Need for Full Integration of Snakebite Envenoming within a Global Strategy to Combat the Neglected Tropical Diseases: The Way Forward. PLoS Negl. Trop. Dis., 7. · DOI
  9. Williams, 2010, The Global Snake Bite Initiative: An antidote for snake bite, Lancet, 375, 89, 10.1016/S0140-6736(09)61159-4 · DOI · Paper page
  10. Williams, D.J., Faiz, M.A., Abela-Ridder, B., Ainsworth, S., Bulfone, T.C., Nickerson, A.D., Habib, A.G., Junghanss, T., Fan, H.W., and Turner, M. (2019). Strategy for a globally coordinated response to a priority neglected tropical disease: Snakebite envenoming. PLoS Negl. Trop. Dis., 13. · DOI · Paper page
  11. Marcelino, 2018, The history of antivenoms development: Beyond Calmette and Vital Brazil, Toxicon, 150, 86, 10.1016/j.toxicon.2018.05.008 · DOI
  12. Vargas, 2018, Current technology for the industrial manufacture of snake antivenoms, Toxicon, 151, 63, 10.1016/j.toxicon.2018.06.084 · DOI · Paper page
  13. Herrera, 2013, Pathogenic mechanisms underlying adverse reactions induced by intravenous administration of snake antivenoms, Toxicon, 76, 63, 10.1016/j.toxicon.2013.09.010 · DOI
  14. Ryan, 2016, Adverse reactions to snake antivenom, and their prevention and treatment, Br. J. Clin. Pharmacol., 81, 446, 10.1111/bcp.12739 · DOI · Paper page
  15. Sharma, 2004, Impact of snake bites and determinants of fatal outcomes in Southeastern Nepal, Am. J. Trop. Med. Hyg., 71, 234, 10.4269/ajtmh.2004.71.234 · doi:10.4269/ajtmh.2004.71.234
  16. Habib, 2011, Factors affecting snakebite mortality in north-eastern Nigeria, Int. Health, 3, 50, 10.1016/j.inhe.2010.08.001 · doi:10.1016/j.inhe.2010.08.001
  17. Chippaux, 2011, Estimate of the burden of snakebites in sub-Saharan Africa: A meta-analytic approach, Toxicon, 57, 586, 10.1016/j.toxicon.2010.12.022 · DOI
  18. Sachett, 2018, Snakebites as cause of deaths in the Western Brazilian Amazon: Why and who dies? Deaths from snakebites in the Amazon, Toxicon, 145, 15, 10.1016/j.toxicon.2018.02.041 · DOI
  19. Rojas, 1998, Neutralization of local tissue damage induced by Bothrops asper (terciopelo) snake venom, Toxicon, 36, 1529, 10.1016/S0041-0101(98)00145-7 · DOI · Paper page
  20. Rivel, 2016, Pathogenesis of dermonecrosis induced by venom of the spitting cobra, Naja nigricollis: An experimental study in mice, Toxicon, 119, 171, 10.1016/j.toxicon.2016.06.006 · DOI
  21. Williams, S.S., Wijesinghe, C.A., Jayamanne, S.F., Buckley, N.A., Dawson, A.H., Lalloo, D.G., and de Silva, H.J. (2011). Delayed psychological morbidity associated with snakebite envenoming. PLoS Negl. Trop. Dis., 5. · DOI
  22. Waiddyanatha, S., Silva, A., Siribaddana, S., and Isbister, G.K. (2019). Long-term effects of snake envenoming. Toxins, 11. · DOI · Paper page
  23. 2012, Improving antivenom availability and accessibility: Science, technology, and beyond, Toxicon, 60, 676, 10.1016/j.toxicon.2012.02.008 · DOI · Paper page
  24. Williams, 2010, Snakebite envenoming from a global perspective: Towards an integrated approach, Toxicon, 56, 1223, 10.1016/j.toxicon.2009.11.020 · DOI · Paper page
  25. Fan, 2018, History and perspectives on how to ensure antivenom accessibility in the most remote areas in Brazil, Toxicon, 151, 15, 10.1016/j.toxicon.2018.06.070 · DOI
  26. Cristino, J.S., Salazar, G.M., Machado, V.A., Honorato, E., Farias, A.S., Vissoci, J.R.N., Neto, A.V.S., Lacerda, M., Wen, F.H., and Monteiro, W.M. (2021). A painful journey to antivenom: The therapeutic itinerary of snakebite patients in the Brazilian Amazon (the QUALISnake study). PLoS Negl. Trop. Dis., 15. · DOI
  27. Petras, 2011, Snake venomics of African spitting cobras: Toxin composition and assessment of congeneric cross-reactivity of the Pan-African EchiTAb-Plus-ICP antivenom by antivenomics and neutralization approaches, J. Proteome Res., 10, 1266, 10.1021/pr101040f · DOI · Paper page
  28. Angulo, 2011, Venomic and Antivenomic Analyses of the Central American Coral Snake, Micrurus nigrocinctus (Elapidae), J. Proteome Res., 10, 1816, 10.1021/pr101091a · DOI
  29. Ainsworth, S., Menzies, S.K., Casewell, N.R., and Harrison, R.A. (2020). An analysis of preclinical efficacy testing of antivenoms for sub-Saharan Africa: Inadequate independent scrutiny and poor-quality reporting are barriers to improving snakebite treatment and management. PLoS Negl. Trop. Dis., 14. · DOI
  30. Laustsen, 2016, From Fangs to Pharmacology: The Future of Snakebite Envenoming Therapy, Curr. Pharm. Des., 22, 5270, 10.2174/1381612822666160623073438 · DOI · Paper page
  31. Laustsen, 2018, Pros and cons of different therapeutic antibody formats for recombinant antivenom development, Toxicon, 146, 151, 10.1016/j.toxicon.2018.03.004 · DOI · Paper page
  32. Huet, 2018, A synthetic biology approach for consistent production of plant-made recombinant polyclonal antibodies against snake venom toxins, Plant Biotechnol. J., 16, 727, 10.1111/pbi.12823 · DOI
  33. Clare, 2021, Small Molecule Drug Discovery for Neglected Tropical Snakebite, Trends Pharmacol. Sci., 42, 340, 10.1016/j.tips.2021.02.005 · DOI · Paper page
  34. Fry, 2009, Evolution and diversification of the Toxicofera reptile venom system, J. Proteom., 72, 127, 10.1016/j.jprot.2009.01.009 · DOI
  35. Calvete, 2017, Venomics: Integrative venom proteomics and beyond, Biochem. J., 474, 611, 10.1042/BCJ20160577 · DOI · Paper page
  36. Lomonte, B., and Calvete, J.J. (2017). Strategies in “snake venomics” aiming at an integrative view of compositional, functional, and immunological characteristics of venoms. J. Venom. Anim. Toxins Incl. Trop. Dis., 23. · DOI · Paper page
  37. Suryamohan, 2020, The Indian cobra reference genome and transcriptome enables comprehensive identification of venom toxins, Nat. Genet., 52, 106, 10.1038/s41588-019-0559-8 · DOI · Paper page
  38. Calvete, 2014, Omics meets biology: Application to the design and preclinical assessment of antivenoms, Toxins, 6, 3388, 10.3390/toxins6123388 · doi:10.3390/toxins6123388
  39. Laustsen, 2015, Selecting key toxins for focused development of elapid snake antivenoms and inhibitors guided by a Toxicity Score, Toxicon, 104, 43, 10.1016/j.toxicon.2015.07.334 · DOI
  40. Lomonte, 2014, Venomous snakes of Costa Rica: Biological and medical implications of their venom proteomic profiles analyzed through the strategy of snake venomics, J. Proteom., 105, 323, 10.1016/j.jprot.2014.02.020 · DOI
  41. Tasoulis, T., and Isbister, G.K. (2017). A review and database of snake venom proteomes. Toxins, 9. · DOI · Paper page
  42. Junqueira-de-Azevedo, I.L.M., Campos, P.F., Ching, A.T.C., and Mackessy, S.P. (2016). Colubrid Venom Composition: An-Omics Perspective. Toxins, 8. · DOI · Paper page
  43. Fox, 2008, Insights into and speculations about snake venom metalloproteinase (SVMP) synthesis, folding and disulfide bond formation and their contribution to venom complexity, FEBS J., 275, 3016, 10.1111/j.1742-4658.2008.06466.x · DOI · Paper page
  44. Zelanis, 2019, Deep Profiling of the Cleavage Specificity and Human Substrates of Snake Venom Metalloprotease HF3 by Proteomic Identification of Cleavage Site Specificity (PICS) Using Proteome Derived Peptide Libraries and Terminal Amine Isotopic Labeling of Substrates (TAILS) N-Terminomics, J. Proteome Res., 18, 3419, 10.1021/acs.jproteome.9b00325 · DOI
  45. Kalogeropoulos, K., Treschow, A.F., Auf Dem Keller, U., Escalante, T., Rucavado, A., Gutiérrez, J.M., Laustsen, A.H., and Workman, C.T. (2019). Protease activity profiling of snake venoms using high-throughput peptide screening. Toxins, 11. · DOI
  46. De Lima, M.E., De Castro, A.M., Martin-Eauclaire, M.F., and Rochat, H. (2009). Snake venom metalloproteinases. Structure, function and effects on snake bite pathology. Animal Toxins: State of the Art—Perspectives in Health and Biotechnology, Editora UFMG. · doi:10.1590/s1678-91992009000300021
  47. Teixeira, 2005, Inflammatory effects of snake venom metalloproteinases, Mem. Inst. Oswaldo Cruz, 100, 181, 10.1590/S0074-02762005000900031 · DOI
  48. Escalante, 2008, Skin Pathology Induced by Snake Venom Metalloproteinase: Acute Damage, Revascularization, and Re-epithelization in a Mouse Ear Model, J. Investig. Dermatol., 128, 2421, 10.1038/jid.2008.118 · DOI
  49. Romero, 1995, Skeletal muscle necrosis and regeneration after injection of BaH1, a hemorrhagic metalloproteinase isolated from the venom of the snake Bothrops asper (Terciopelo), Exp. Mol. Pathol., 62, 28, 10.1006/exmp.1995.1004 · DOI
  50. Hernández, R., Cabalceta, C., Saravia-Otten, P., Chaves, A., Gutiérrez, J.M., and Rucavado, A. (2011). Poor regenerative outcome after skeletal muscle necrosis induced by Bothrops asper venom: Alterations in microvasculature and nerves. PLoS ONE, 6. · DOI
  51. Williams, H.F., Mellows, B.A., Mitchell, R., Sfyri, P., Layfield, H.J., Salamah, M., Vaiyapuri, R., Collins-Hooper, H., Bicknell, A.B., and Matsakas, A. (2019). Mechanisms underpinning the permanent muscle damage induced by snake venom metalloprotease. PLoS Negl. Trop. Dis., 13. · DOI
  52. Kamiguti, 2000, Mass spectrophotometric evidence for P-III/P-IV metalloproteinases in the venom of the Boomslang (Dispholidus typus), Toxicon, 38, 1613, 10.1016/S0041-0101(00)00089-1 · doi:10.1016/s0041-0101(00)00089-1
  53. Kini, 2003, Excitement ahead: Structure, function and mechanism of snake venom phospholipase A2 enzymes, Toxicon, 42, 827, 10.1016/j.toxicon.2003.11.002 · DOI · Paper page
  54. Kini, R.M. (1997). Phospholipase A2: Structure and catalytic properties. Venom Phospholipase A2 Enzymes. Structure, Function and Mechanism, Wiley.
  55. Fry, B.G. (2015). Group I phospholipase A2 enzymes. Venomous Reptiles & Their Toxins. Evolution, Pathophysiology & Biodiscovery, Oxford University Press.
  56. Fry, B.G. (2015). Group II phospholipase A2 enzymes. Venomous Reptiles & Their Toxins. Evolution, Pathophysiology & Biodiscovery, Oxford University Press.
  57. Kini, 1989, A model to explain the pharmacological effects of snake venom phospholipases A2, Toxicon, 27, 613, 10.1016/0041-0101(89)90013-5 · DOI · Paper page
  58. Lomonte, 2012, Snake venom Lys49 myotoxins: From phospholipases A 2 to non-enzymatic membrane disruptors, Toxicon, 60, 520, 10.1016/j.toxicon.2012.02.007 · DOI · Paper page
  59. Kessler, 2017, The three-finger toxin fold: A multifunctional structural scaffold able to modulate cholinergic functions, J. Neurochem., 142, 7, 10.1111/jnc.13975 · DOI · Paper page
  60. Kini, 2010, Structure, function and evolution of three-finger toxins: Mini proteins with multiple targets, Toxicon, 56, 855, 10.1016/j.toxicon.2010.07.010 · DOI · Paper page
  61. Utkin, 2019, Novel long-chain neurotoxins from Bungarus candidus distinguish the two binding sites in muscle-type nicotinic acetylcholine receptors, Biochem. J., 476, 1285, 10.1042/BCJ20180909 · DOI
  62. Nirthanan, 2004, Three-Finger α-Neurotoxins and the Nicotinic Acetylcholine Receptor, Forty Years On, J. Pharmacol. Sci., 94, 1, 10.1254/jphs.94.1 · DOI · Paper page
  63. Warrell, 2010, Snake bite, Lancet, 375, 77, 10.1016/S0140-6736(09)61754-2 · DOI · Paper page
  64. Mackessy, S.P. (2010). Fasciculins. Toxins from mamba venoms that inhibit acetylcholinesterase. Handbook of Venoms and Toxins of Reptiles, CRC Press.
  65. Banerjee, 2007, Biophysical characterization of anticoagulant hemextin AB complex from the venom of snake Hemachatus haemachatus, Biophys. J., 93, 3963, 10.1529/biophysj.106.100164 · DOI
  66. Harvey, 1983, Effect of phospholipase A on actions of cobra venom cardiotoxins on erythrocytes and skeletal muscle, BBA Biomembr., 728, 215, 10.1016/0005-2736(83)90474-1 · DOI
  67. Konshina, 2012, Structure and Dynamics of Cardiotoxins, Curr. Protein Pept. Sci., 13, 570, 10.2174/138920312803582960 · DOI
  68. Ownby, 1993, Cardiotoxin 1 from cobra (Naja naja atra) venom causes necrosis of skeletal muscle in vivo, Toxicon, 31, 697, 10.1016/0041-0101(93)90376-T · DOI
  69. Pratanaphon, 1997, Production of highly potent horse antivenom against the Thai cobra (Naja kaouthia), Vaccine, 15, 1523, 10.1016/S0264-410X(97)00098-4 · doi:10.1016/s0264-410x(97)00098-4
  70. Chippaux, 2008, Characterization of a new polyvalent antivenom (Antivipmyn® Africa) against African vipers and elapids, Toxicon, 52, 881, 10.1016/j.toxicon.2008.09.002 · doi:10.1016/j.toxicon.2008.09.002
  71. Tan, 2017, Venomics of Naja sputatrix, the Javan spitting cobra: A short neurotoxin-driven venom needing improved antivenom neutralization, J. Proteom., 157, 18, 10.1016/j.jprot.2017.01.018 · DOI
  72. Serrano, 2005, Snake venom serine proteinases: Sequence homology vs. substrate specificity, a paradox to be solved, Toxicon, 45, 1115, 10.1016/j.toxicon.2005.02.020 · DOI · Paper page
  73. Vaiyapuri, 2012, Sequence and phylogenetic analysis of viper venom serine proteases, Bioinformation, 8, 763, 10.6026/97320630008563 · doi:10.6026/97320630008563
  74. Mackessy, S.P. (2010). Thrombin-like snake venom serine proteinases. Handbook of Venoms and Toxins of Reptiles, CRC Press.
  75. Ullah, 2018, Thrombin-like enzymes from snake venom: Structural characterization and mechanism of action, Int. J. Biol. Macromol., 114, 788, 10.1016/j.ijbiomac.2018.03.164 · DOI
  76. Debono, 2019, Habu coagulotoxicity: Clinical implications of the functional diversification of Protobothrops snake venoms upon blood clotting factors, Toxicol. Vitr., 55, 62, 10.1016/j.tiv.2018.11.008 · DOI
  77. White, 2005, Snake venoms and coagulopathy, Toxicon, 45, 951, 10.1016/j.toxicon.2005.02.030 · DOI · Paper page
  78. Kini, 2005, The intriguing world of prothrombin activators from snake venom, Toxicon, 45, 1133, 10.1016/j.toxicon.2005.02.019 · DOI
  79. Johnston, 2017, The Australian snakebite project, 2005–2015 (ASP-20), Med. J. Aust., 207, 119, 10.5694/mja17.00094 · doi:10.5694/mja17.00094
  80. Harvey, 2012, Dendrotoxins: Structure-Activity Relationships and Effects on Potassium Ion Channels, Curr. Med. Chem., 11, 3065, 10.2174/0929867043363820 · DOI · Paper page
  81. Warrell, D.A. (1995). Clinical toxicology of snakebite in Africa and the Middle East/Arabian peninsula. Handbook of Clinical Toxicology of Animal Venoms and Poisons, CRC Press.
  82. Mackessy, S.P. (2010). Sarafotoxins, the snake venom homologs of the endothelins. Handbook of Venoms and Toxins of Reptiles, CRC Press.
  83. Rucavado, 2018, Systemic vascular leakage induced in mice by Russell’s viper venom from Pakistan, Sci. Rep., 8, 16088, 10.1038/s41598-018-34363-1 · DOI
  84. Kendre, 2018, Capillary leak syndrome in Daboia russelii bite—A complication associated with poor outcome, Trans. R. Soc. Trop. Med. Hyg., 112, 88, 10.1093/trstmh/try026 · DOI
  85. Mebs, 1990, Myotoxic components of snake venoms: Their biochemical and biological activities, Pharmacol. Ther., 48, 223, 10.1016/0163-7258(90)90081-C · DOI · Paper page
  86. Morita, 2005, Structures and functions of snake venom CLPs (C-type lectin-like proteins) with anticoagulant-, procoagulant-, and platelet-modulating activities, Toxicon, 45, 1099, 10.1016/j.toxicon.2005.02.021 · DOI · Paper page
  87. Clemetson, 2007, Snake Venom Proteins Affecting Platelets and Their Applications to Anti-Thrombotic Research, Curr. Pharm. Des., 13, 2887, 10.2174/138161207782023702 · DOI
  88. Matsui, 2005, Structure and function of snake venom toxins interacting with human von Willebrand factor, Toxicon, 45, 1075, 10.1016/j.toxicon.2005.02.023 · DOI
  89. Rucavado, 2001, Characterization of aspercetin, a platelet aggregating component from the venom of the snake Bothrops asper which induces thrombocytopenia and potentiates metalloproteinase-induced hemorrhage, Thromb. Haemost., 85, 710, 10.1055/s-0037-1615657 · DOI
  90. Rucavado, 2005, Thrombocytopenia and platelet hypoaggregation induced by Bothrops asper snake venom hemorrhage, Thromb. Haemost., 91, 123
  91. Santoro, 2008, Haematological evaluation of patients bitten by the jararaca, Bothrops jararaca, in Brazil, Toxicon, 51, 1440, 10.1016/j.toxicon.2008.03.018 · DOI
  92. Oliveira, S.S., Alves, E.C., Santos, A.S., Pereira, J.P.T., Sarraff, L.K.S., Nascimento, E.F., De-Brito-sousa, J.D., Sampaio, V.S., Lacerda, M.V.G., and Sachett, J.A.G. (2019). Factors associated with systemic bleeding in Bothrops envenomation in a tertiary hospital in the Brazilian Amazon. Toxins, 11. · doi:10.3390/toxins11010022
  93. Calvete, 2005, Snake venom disintegrins: Evolution of structure and function, Toxicon, 45, 1063, 10.1016/j.toxicon.2005.02.024 · DOI · Paper page
  94. Tadokoro, T., Modahl, C.M., Maenaka, K., and Aoki-Shioi, N. (2020). Cysteine-rich secretory proteins (CRISPs) from venomous snakes: An overview of the functional diversity in a large and underappreciated superfamily. Toxins, 12. · DOI
  95. Hayashi, 2005, The Bradykinin-potentiating peptides from venom gland and brain of Bothrops jararaca contain highly site specific inhibitors of the somatic angiotensin-converting enzyme, Toxicon, 45, 1163, 10.1016/j.toxicon.2005.02.017 · DOI
  96. Pla, 2013, Snake venomics of Lachesis muta rhombeata and genus-wide antivenomics assessment of the paraspecific immunoreactivity of two antivenoms evidence the high compositional and immunological conservation across Lachesis, J. Proteom., 89, 112, 10.1016/j.jprot.2013.05.028 · DOI
  97. Cavaillon, J.M., and Singer, M.E. (2018). Venoms. Inflammation: From Molecular and Cellular Mechanisms to the Clinic, Wiley. · DOI
  98. Bickler, P.E. (2020). Amplification of Snake Venom Toxicity by Endogenous Signaling Pathways. Toxins, 12. · DOI
  99. Zornetta, I., Caccin, P., Fernandez, J., Lomonte, B., Gutierrez, J.M., and Montecucco, C. (2012). Envenomations by Bothrops and Crotalus snakes induce the release of mitochondrial alarmins. PLoS Negl. Trop. Dis., 6. · DOI
  100. Rucavado, A., Nicolau, C.A., Escalante, T., Kim, J., Herrera, C., Gutiérrez, J.M., and Fox, J.W. (2016). Viperid envenomation wound exudate contributes to increased vascular permeability via a DAMPs/TLR-4 mediated pathway. Toxins, 8. · DOI · Paper page
  101. Moreira, 2016, The role of TLR2 in the acute inflammatory response induced by Bothrops atrox snake venom, Toxicon, 118, 121, 10.1016/j.toxicon.2016.04.042 · DOI
  102. Zoccal, K.F., Bitencourt, C.S., Paula-Silva, F.W.G., Sorgi, C.A., Bordon, K.C.F., Arantes, E.C., and Faccioli, L.H. (2014). TLR2, TLR4 and CD14 recognize venom-associated molecular patterns from Tityus serrulatus to induce macrophage-derived inflammatory mediators. PLoS ONE, 9. · DOI
  103. Sharma, 2015, Oxidative stress-induced methemoglobinemia is the silent killer during snakebite: A novel and strategic neutralization by melatonin, J. Pineal Res., 59, 240, 10.1111/jpi.12256 · DOI
  104. Gold, 1996, Neostigmine for the treatment of neurotoxicity following envenomation by the Asiatic cobra, Ann. Emerg. Med., 28, 87, 10.1016/S0196-0644(96)70142-7 · doi:10.1016/s0196-0644(96)70142-7
  105. Lewin, M.R., Samuel, S.P., Wexler, D.S., Bickler, P., Vaiyapuri, S., and Mensh, B.D. (2014). Early treatment with intranasal neostigmine reduces mortality in a mouse model of Naja naja (Indian cobra) envenomation. J. Trop. Med., 2014. · doi:10.1155/2014/131835
  106. Faiz, 2017, Bites by the Monocled Cobra, Naja kaouthia, in Chittagong Division, Bangladesh: Epidemiology, clinical features of envenoming and management of 70 identified cases, Am. J. Trop. Med. Hyg., 96, 876, 10.4269/ajtmh.16-0842 · DOI · Paper page
  107. Stazi, M., D’este, G., Mattarei, A., Negro, S., Lista, F., Rigoni, M., Megighian, A., and Montecucco, C. (2020). An agonist of the cxcr4 receptor accelerates the recovery from the peripheral neuroparalysis induced by taipan snake envenomation. PLoS Negl. Trop. Dis., 14. · DOI
  108. Gutiérrez, J.M., Escalante, T., Hernández, R., Gastaldello, S., Saravia-Otten, P., and Rucavado, A. (2018). Why is skeletal muscle regeneration impaired after myonecrosis induced by viperid snake venoms?. Toxins, 10. · DOI
  109. Sanchez-Castro, E.E., Pajuelo-Reyes, C., Tejedo, R., Soria-Juan, B., Tapia-Limonchi, R., Andreu, E., Hitos, A.B., Martin, F., Cahuana, G.M., and Guerra-Duarte, C. (2021). Mesenchymal Stromal Cell-Based Therapies as Promising Treatments for Muscle Regeneration after Snakebite Envenoming. Front. Immunol., 11. · DOI
  110. Knudsen, 2019, Engineering and design considerations for next-generation snakebite antivenoms, Toxicon, 167, 67, 10.1016/j.toxicon.2019.06.005 · DOI
  111. Knudsen, C., Casewell, N.R., Lomonte, B., Gutiérrez, J.M., Vaiyapuri, S., and Laustsen, A.H. (2020). Novel Snakebite Therapeutics Must Be Tested in Appropriate Rescue Models to Robustly Assess Their Preclinical Efficacy. Toxins, 12. · DOI
  112. Mors, 2000, Plant natural products active against snake bite—The molecular approach, Phytochemistry, 55, 627, 10.1016/S0031-9422(00)00229-6 · DOI · Paper page
  113. Soares, 2005, Medicinal Plants with Inhibitory Properties Against Snake Venoms, Curr. Med. Chem., 12, 2625, 10.2174/092986705774370655 · DOI · Paper page
  114. Carvalho, B.M.A., Santos, J.D.L., Xavier, B.M., Almeida, J.R., Resende, L.M., Martins, W., Marcussi, S., Marangoni, S., Stábeli, R.G., and Calderon, L.A. (2013). Snake venom PLA2s inhibitors isolated from Brazilian plants: Synthetic and natural molecules. BioMed Res. Int., 2013. · DOI
  115. Shabbir, 2014, Protective activity of medicinal plants and their isolated compounds against the toxic effects from the venom of Naja (cobra) species, J. Ethnopharmacol., 157, 222, 10.1016/j.jep.2014.09.039 · DOI
  116. Félix-Silva, J., Silva-Junior, A.A., Zucolotto, S.M., and Fernandes-Pedrosa, M.D.F. (2017). Medicinal Plants for the Treatment of Local Tissue Damage Induced by Snake Venoms: An Overview from Traditional Use to Pharmacological Evidence. Evid. Based Complementary Altern. Med., 2017. · DOI
  117. 2017, The potential of aqueous extracts of Bellucia dichotoma Cogn. (Melastomataceae) to inhibit the biological activities of Bothrops atrox venom: A comparison of specimens collected in the states of Pará and Amazonas, Brazil, J. Ethnopharmacol., 196, 168, 10.1016/j.jep.2016.12.031 · DOI
  118. Otero, 2004, Neutralization of the edema-forming, defibrinating and coagulant effects of Bothrops asper venom by extracts of plants used by healers in Columbia, Braz. J. Med. Biol. Res., 37, 969, 10.1590/S0100-879X2004000700005 · doi:10.1590/s0100-879x2004000700005
  119. Castro, 2005, Inhibitory effects of Piper umbellatum and Piper peltatum extracts towards myotoxic phospholipases A2 from Bothrops snake venoms: Isolation of 4-nerolidylcatechol as active principle, Phytochemistry, 66, 1017, 10.1016/j.phytochem.2005.03.026 · doi:10.1016/j.phytochem.2005.03.026
  120. 2015, Plants used to treat snakebites in Santarém, western Pará, Brazil: An assessment of their effectiveness in inhibiting hemorrhagic activity induced by Bothrops jararaca venom, J. Ethnopharmacol., 161, 224, 10.1016/j.jep.2014.12.020 · DOI
  121. Quintana, 2015, Extracts of Renealmia alpinia (rottb.) MAAS protect against lethality and systemic hemorrhage induced by Bothrops asper venom: Insights from a model with extract administration before venom injection, Toxins, 7, 1532, 10.3390/toxins7051532 · DOI
  122. Otero, 2000, Snakebites and ethnobotany in the northwest region of Colombia. Part II: Neutralization of lethal and enzymatic effects of Bothrops atrox venom, J. Ethnopharmacol., 71, 505, 10.1016/S0378-8741(99)00197-X · doi:10.1016/s0378-8741(99)00197-x
  123. Singh, 2002, Medical ethnobotany of the tribals of Sonaghati of Sonbhadra district, Uttar Pradesh, India, J. Ethnopharmacol., 81, 31, 10.1016/S0378-8741(02)00028-4 · DOI · Paper page
  124. Chen, 2014, Effect of externally applied Jidesheng anti-venom on skin and soft-tissue necrosis after Chinese cobra bite: A retrospective study, J. Tradit. Chin. Med., 34, 150, 10.1016/S0254-6272(14)60069-8 · doi:10.1016/s0254-6272(14)60069-8
  125. Chandra, 2002, Structural basis of phospholipase A2 inhibition for the synthesis of prostaglandins by the plant alkaloid aristolochic acid from a 1.7 Å crystal structure, Biochemistry, 41, 10914, 10.1021/bi0258593 · DOI
  126. Dos Santos, J.I., Cardoso, F.F., Soares, A.M., dal Pai Silva, M., Gallacci, M., and Fontes, M.R.M. (2011). Structural and functional studies of a bothropic myotoxin complexed to rosmarinic acid: New insights into Lys49-PLA 2 inhibition. PLoS ONE, 6. · DOI · Paper page
  127. Shimabuku, 2011, Crystallization and preliminary X-ray diffraction analysis of a Lys49-phospholipase A2 complexed with caffeic acid, a molecule with inhibitory properties against snake venoms, Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun., 67, 249, 10.1107/S1744309110051407 · doi:10.1107/s1744309110051407
  128. Osorio, 2014, The biflavonoid morelloflavone inhibits the enzymatic and biological activities of a snake venom phospholipase A2, Chem. Biol. Interact., 220, 94, 10.1016/j.cbi.2014.06.015 · DOI
  129. Preciado, L.M., Comer, J., Núñez, V., Rey-Súarez, P., and Pereañez, J.A. (2018). Inhibition of a snake venom metalloproteinase by the flavonoid myricetin. Molecules, 23. · DOI
  130. Kumar, M.S., Amjesh, R., Bhaskaran, S., Delphin, R.D., Nair, A.S., and Sudhakaran, P.R. (2019). Molecular docking and dynamic studies of crepiside E beta glucopyranoside as an inhibitor of snake venom PLA2. J. Mol. Model., 25. · DOI
  131. Mackessy, S.P. (2010). Natural inhibitors. Innate immunity to snake venoms. Handbook of Venoms and Toxins of Reptiles, CRC Press.
  132. Bastos, V.A., Gomes-Neto, F., Perales, J., Neves-Ferreira, A.G.C., and Valente, R.H. (2016). Natural inhibitors of snake venom metalloendopeptidases: History and current challenges. Toxins, 8. · DOI
  133. Lizano, 2003, Natural phospholipase A2 myotoxin inhibitor proteins from snakes, mammals and plants, Toxicon, 42, 963, 10.1016/j.toxicon.2003.11.007 · DOI
  134. Rocha, 2002, Functional analysis of DM64, an antimyotoxic protein with immunoglobulin-like structure from Didelphis marsupialis serum, Eur. J. Biochem., 269, 6052, 10.1046/j.1432-1033.2002.03308.x · DOI
  135. Metz, 2006, Mast cells can enhance resistance to snake and honeybee venoms, Science, 313, 526, 10.1126/science.1128877 · DOI · Paper page
  136. Anderson, E., Stavenhagen, K., Kolarich, D., Sommerhoff, C.P., Maurer, M., and Metz, M. (2018). Human mast cell tryptase is a potential treatment for snakebite envenoming across multiple snake species. Front. Immunol., 9. · DOI · Paper page
  137. Melo, 1993, Antagonism of the myotoxic effects of Bothrops jararacussu venom and bothropstoxin by polyanions, Toxicon, 31, 285, 10.1016/0041-0101(93)90146-A · DOI
  138. Lomonte, 1994, Neutralization of the cytolytic and myotoxic activities of phospholipases A2 from Bothrops asper snake venom by glycosaminoglycans of the heparin/heparan sulfate family, Biochem. Pharmacol., 47, 1509, 10.1016/0006-2952(94)90525-8 · doi:10.1016/0006-2952(94)90525-8
  139. Itoh, 2002, Matrix metalloproteinases in cancer, Essays Biochem., 38, 21, 10.1042/bse0380021 · DOI · Paper page
  140. Nissinen, 2014, Matrix metalloproteinases in inflammation, Biochim. Biophys. Acta Gen. Subj., 1840, 2571, 10.1016/j.bbagen.2014.03.007 · DOI · Paper page
  141. Gharib, 2018, Matrix metalloproteinases in emphysema, Matrix Biol., 73, 34, 10.1016/j.matbio.2018.01.018 · DOI
  142. Conrad, 2019, ADAM8 in invasive cancers: Links to tumor progression, metastasis, and chemoresistance, Clin. Sci., 133, 83, 10.1042/CS20180906 · DOI
  143. Fischer, 2019, Design and Structural Evolution of Matrix Metalloproteinase Inhibitors, Chem. A Eur. J., 25, 7960, 10.1002/chem.201805361 · DOI
  144. Mannello, 2005, Matrix Metalloproteinase Inhibitors as Anticancer Therapeutics, Curr. Cancer Drug Targets, 5, 285, 10.2174/1568009054064615 · DOI · Paper page
  145. Zhong, 2018, Recent opportunities in matrix metalloproteinase inhibitor drug design for cancer, Expert Opin. Drug Discov., 13, 75, 10.1080/17460441.2018.1398732 · DOI
  146. Dufour, 2011, Small-molecule anticancer compounds selectively target the hemopexin domain of matrix metalloproteinase-9, Cancer Res., 71, 4977, 10.1158/0008-5472.CAN-10-4552 · DOI · Paper page
  147. Escalante, 2000, Effectiveness of batimastat, a synthetic inhibitor of matrix metalloproteinases, in neutralizing local tissue damage induced by BaP1, a hemorrhagic metalloproteinase from the venom of the snake Bothrops asper, Biochem. Pharmacol., 60, 269, 10.1016/S0006-2952(00)00302-6 · DOI
  148. Rucavado, 2000, Inhibition of local hemorrhage and dermonecrosis induced by Bothrops asper snake venom: Effectiveness of early in situ administration of the peptidomimetic metalloproteinase inhibitor batimastat and the chelating agent CaNa2EDTA, Am. J. Trop. Med. Hyg., 63, 313, 10.4269/ajtmh.2000.63.313 · DOI · Paper page
  149. Arias, 2017, Peptidomimetic hydroxamate metalloproteinase inhibitors abrogate local and systemic toxicity induced by Echis ocellatus (saw-scaled) snake venom, Toxicon, 132, 40, 10.1016/j.toxicon.2017.04.001 · DOI · Paper page
  150. Albulescu, L.O., Xie, C., Ainsworth, S., Alsolaiss, J., Crittenden, E., Dawson, C.A., Softley, R., Bartlett, K.E., Harrison, R.A., and Kool, J. (2020). A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite. Nat. Commun., 11. · DOI · Paper page
  151. Borkow, 1997, Inhibition of toxic activities of Bothrops asper venom and other crotalid snake venoms by a novel neutralizing mixture, Toxicol. Appl. Pharmacol., 147, 442, 10.1006/taap.1997.8285 · doi:10.1006/taap.1997.8285
  152. Albulescu, L.O., Hale, M.S., Ainsworth, S., Alsolaiss, J., Crittenden, E., Calvete, J.J., Evans, C., Wilkinson, M.C., Harrison, R.A., and Kool, J. (2020). Preclinical validation of a repurposed metal chelator as an early-intervention therapeutic for hemotoxic snakebite. Sci. Transl. Med., 12. · DOI · Paper page
  153. Rudresha, G.V., Urs, A.P., Manjuprasanna, V.N., Milan Gowda, M.D., Jayachandra, K., Rajaiah, R., and Vishwanath, B.S. (2021). Echis carinatus snake venom metalloprotease-induced toxicities in mice: Therapeutic intervention by a repurposed drug, tetraethyl thiuram disulfide (Disulfiram). PLoS Negl. Trop. Dis., 15. · DOI
  154. Rucavado, 2008, Assessment of metalloproteinase inhibitors clodronate and doxycycline in the neutralization of hemorrhage and coagulopathy induced by Bothrops asper snake venom, Toxicon, 52, 754, 10.1016/j.toxicon.2008.08.009 · DOI
  155. Nakamoto, M., Escalante, T., Gutiérrez, J.M., and Shea, K.J. (2021). A Biomimetic of Endogenous Tissue Inhibitors of Metalloproteinases: Inhibition Mechanism and Contribution of Composition, Polymer Size and Shape to the Inhibitory Effect. Nano Lett., in press. · DOI
  156. Dennis, 2011, Phospholipase A2 enzymes: Physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention, Chem. Rev., 111, 6130, 10.1021/cr200085w · DOI · Paper page
  157. Magrioti, 2013, Phospholipase A2 inhibitors for the treatment of inflammatory diseases: A patent review (2010-present), Expert Opin. Ther. Pat., 23, 333, 10.1517/13543776.2013.754425 · DOI
  158. Murakami, 2017, Regulatory functions of phospholipase A2, Crit. Rev. Immunol., 37, 121, 10.1615/CritRevImmunol.v37.i2-6.20 · DOI · Paper page
  159. Serruys, 2009, Phospholipase A2 inhibitors, Curr. Opin. Lipidol., 20, 327, 10.1097/MOL.0b013e32832dd4c7 · DOI
  160. Adis, 2011, Varespladib, Am. J. Cardiovasc. Drugs, 11, 137, 10.2165/11533650-000000000-00000 · DOI · Paper page
  161. Nicholls, 2014, Varespladib and cardiovascular events in patients with an acute coronary syndrome: The VISTA-16 randomized clinical trial, JAMA J. Am. Med. Assoc., 311, 252, 10.1001/jama.2013.282836 · DOI · Paper page
  162. Rosenson, 2010, Effects of varespladib methyl on biomarkers and major cardiovascular events in acute coronary syndrome patients, J. Am. Coll. Cardiol., 56, 1079, 10.1016/j.jacc.2010.06.015 · DOI
  163. Lewin, M., Samuel, S., Merkel, J., and Bickler, P. (2016). Varespladib (LY315920) appears to be a potent, broad-spectrum, inhibitor of snake venom phospholipase A2 and a possible pre-referral treatment for envenomation. Toxins, 8. · DOI · Paper page
  164. Lewin, M.R., Gutiérrez, J.M., Samuel, S.P., Herrera, M., Bryan-Quirós, W., Lomonte, B., Bickler, P.E., Bulfone, T.C., and Williams, D.J. (2018). Delayed oral LY333013 rescues mice from highly neurotoxic, lethal doses of papuan taipan (Oxyuranus scutellatus) venom. Toxins, 10. · DOI · Paper page
  165. Lewin, M.R., Gilliam, L.L., Gilliam, J., Samuel, S.P., Bulfone, T.C., Bickler, P.E., and Gutiérrez, J.M. (2018). Delayed LY333013 (oral) and LY315920 (intravenous) reverse severe neurotoxicity and rescue juvenile pigs from lethal doses of Micrurus fulvius (eastern coral snake) venom. Toxins, 10. · DOI · Paper page
  166. Lewin, 2020, Varespladib (LY315920) inhibits neuromuscular blockade induced by Oxyuranus scutellatus venom in a nerve-muscle preparation, Toxicon, 187, 101, 10.1016/j.toxicon.2020.08.023 · DOI
  167. Lewin, 2019, Neutralizing properties of LY315920 toward snake venom group I and II myotoxic phospholipases A2, Toxicon, 157, 1, 10.1016/j.toxicon.2018.11.292 · DOI · Paper page
  168. Xiao, H., Li, H., Zhang, D., Li, Y., Sun, S., and Huang, C. (2018). Inactivation of venom PLA2 alleviates myonecrosis and facilitates muscle regeneration in envenomed mice: A time course observation. Molecules, 23. · DOI
  169. Kini, 2005, Structure-function relationships and mechanism of anticoagulant phospholipase A2 enzymes from snake venoms, Toxicon, 45, 1147, 10.1016/j.toxicon.2005.02.018 · DOI · Paper page
  170. Youngman, N.J., Walker, A., Naude, A., Coster, K., Sundman, E., and Fry, B.G. (2020). Varespladib (LY315920) neutralises phospholipase A2 mediated prothrombinase-inhibition induced by Bitis snake venoms. Comp. Biochem. Physiol. Part C Toxicol. Pharmacol., 236. · DOI
  171. Zdenek, 2020, Anticoagulant activity of black snake (Elapidae: Pseudechis) venoms: Mechanisms, potency, and antivenom efficacy, Toxicol. Lett., 330, 176, 10.1016/j.toxlet.2020.05.014 · DOI
  172. Dashevsky, 2021, Anticoagulant Micrurus venoms: Targets and neutralization, Toxicol. Lett., 337, 91, 10.1016/j.toxlet.2020.11.010 · DOI
  173. Lomonte, 1989, A new muscle damaging toxin, myotoxin II, from the venom of the snake Bothrops asper (terciopelo), Toxicon, 27, 725, 10.1016/0041-0101(89)90039-1 · DOI · Paper page
  174. Chacur, 2003, Hyperalgesia induced by Asp49 and Lys49 phospholipases A2 from Bothrops asper snake venom: Pharmacological mediation and molecular determinants, Toxicon, 41, 667, 10.1016/S0041-0101(03)00007-2 · DOI
  175. Zuliani, 2005, Inflammatory events induced by Lys-49 and Asp-49 phospholipases A 2 isolated from Bothrops asper snake venom: Role of catalytic activity, Toxicon, 45, 335, 10.1016/j.toxicon.2004.11.004 · DOI
  176. Salvador, G.H.M., Gomes, A.A.S., Bryan-Quirós, W., Fernández, J., Lewin, M.R., Gutiérrez, J.M., Lomonte, B., and Fontes, M.R.M. (2019). Structural basis for phospholipase A2-like toxin inhibition by the synthetic compound Varespladib (LY315920). Sci. Rep., 9. · DOI · Paper page
  177. Lomonte, 1994, Neutralizing interaction between heparins and myotoxin II, a lysine 49 phospholipase A2 from Bothrops asper snake venom. Identification of a heparin-binding and cytolytic toxin region by the use of synthetic peptides and molecular modeling, J. Biol. Chem., 269, 29867, 10.1016/S0021-9258(18)43961-0 · DOI · Paper page
  178. Cavalcante, 2003, Antagonism of myotoxic and paralyzing activities of bothropstoxin-I by suramin, Toxicon, 42, 373, 10.1016/S0041-0101(03)00166-1 · DOI
  179. Murakami, 2005, Inhibition of myotoxic activity of Bothrops asper myotoxin II by the anti-trypanosomal drug suramin, J. Mol. Biol., 350, 416, 10.1016/j.jmb.2005.04.072 · DOI
  180. Salvador, G.H.M., Dreyer, T.R., Gomes, A.A.S., Cavalcante, W.L.G., Dos Santos, J.I., Gandin, C.A., De Oliveira Neto, M., Gallacci, M., and Fontes, M.R.M. (2018). Structural and functional characterization of suramin-bound MjTX-I from Bothrops moojeni suggests a particular myotoxic mechanism. Sci. Rep., 8. · DOI
  181. Raw, 1986, Isolation and characterization of a thrombin-like enzyme from the venom of Crotalus durissus terrificus, Braz. J. Med. Biol. Res., 19, 333
  182. Aguiar, 1996, Purification and partial characterization of a thrombin-like/gyroxin enzyme from bushmaster (Lachesis muta rhombeata) venom, Toxicon, 34, 555, 10.1016/0041-0101(95)00159-X · doi:10.1016/0041-0101(95)00159-x
  183. Barber, 2013, Alpha neurotoxins, Toxicon, 66, 47, 10.1016/j.toxicon.2013.01.019 · DOI · Paper page
  184. Albulescu, L.O., Kazandjian, T., Slagboom, J., Bruyneel, B., Ainsworth, S., Alsolaiss, J., Wagstaff, S.C., Whiteley, G., Harrison, R.A., and Ulens, C. (2019). A decoy-receptor approach using nicotinic acetylcholine receptor mimics reveals their potential as novel therapeutics against neurotoxic snakebite. Front. Pharmacol., 10. · DOI
  185. Zdenek, C.N., Harris, R.J., Kuruppu, S., Youngman, N.J., Dobson, J.S., Debono, J., Khan, M., Smith, I., Yarski, M., and Harrich, D. (2019). A taxon-specific and high-throughput method for measuring ligand binding to nicotinic acetylcholine receptors. Toxins, 11. · DOI
  186. Harris, R.J., Youngman, N.J., Zdenek, C.N., Huynh, T.M., Nouwens, A., Hodgson, W.C., Harrich, D., Dunstan, N., Portes-Junior, J.A., and Fry, B.G. (2020). Assessing the binding of venoms from aquatic elapids to the nicotinic acetylcholine receptor orthosteric site of different prey models. Int. J. Mol. Sci., 21. · DOI
  187. El-Aziz, T.M.A., Ravelet, C., Molgo, J., Fiore, E., Pale, S., Amar, M., Al-Khoury, S., Dejeu, J., Fadl, M., and Ronjat, M. (2017). Efficient functional neutralization of lethal peptide toxins in vivo by oligonucleotides. Sci. Rep., 7. · doi:10.1038/s41598-017-07554-5
  188. Taiwe, G.S., Montnach, J., Nicolas, S., De Waard, S., Fiore, E., Peyrin, E., El-Aziz, T.M.A., Amar, M., Molgó, J., and Ronjat, M. (2019). Aptamer efficacies for in vitro and in vivo modulation of αC-conotoxin PrXA pharmacology. Molecules, 24. · doi:10.3390/molecules24020229
  189. Lauridsen, L.H., Shamaileh, H.A., Edwards, S.L., Taran, E., and Veedu, R.N. (2012). Rapid one-step selection method for generating nucleic acid aptamers: Development of a DNA Aptamer against α-bungarotoxin. PLoS ONE, 7. · DOI
  190. Chen, Y.J., Tsai, C.Y., Hu, W.P., and Chang, L. (2016). Sen DNA aptamers against Taiwan banded krait α-bungarotoxin recognize Taiwan cobra cardiotoxins. Toxins, 8. · DOI
  191. Lynagh, 2020, Peptide Inhibitors of the α-Cobratoxin-Nicotinic Acetylcholine Receptor Interaction, J. Med. Chem., 63, 13709, 10.1021/acs.jmedchem.0c01202 · DOI
  192. Lee, 2016, Engineering the Protein Corona of a Synthetic Polymer Nanoparticle for Broad-Spectrum Sequestration and Neutralization of Venomous Biomacromolecules, J. Am. Chem. Soc., 138, 16604, 10.1021/jacs.6b10950 · DOI
  193. O’Brien, J., Lee, S.H., Gutiérrez, J.M., and Shea, K.J. (2018). Engineered nanoparticles bind elapid snake venom toxins and inhibit venom-induced dermonecrosis. PLoS Negl. Trop. Dis., 12. · DOI
  194. Mackessy, S.P. (2010). Hyaluronidases, a Neglected Class of Glycosidases from Snake Venom. Handbook of Venoms and Toxins of Reptiles, CRC Press.
  195. Yingprasertchai, 2003, Hyaluronidase inhibitors (sodium cromoglycate and sodium auro-thiomalate) reduce the local tissue damage and prolong the survival time of mice injected with Naja kaouthia and Calloselasma rhodostoma venoms, Toxicon, 42, 635, 10.1016/j.toxicon.2003.09.001 · DOI
  196. Khedrinia, M., Aryapour, H., and Mianabadi, M. (2019). Prediction of novel inhibitors for Crotalus adamanteus L-amino acid oxidase by repurposing FDA-approved drugs: A virtual screening and molecular dynamics simulation investigation. Drug Chem. Toxicol. · DOI
  197. Chung, 2012, The nuts and bolts of low-level laser (Light) therapy, Ann. Biomed. Eng., 40, 516, 10.1007/s10439-011-0454-7 · DOI · Paper page
  198. Silva, 2018, Photobiomodulation therapy on Bothrops snake venom-induced local pathological effects: A systematic review, Toxicon, 152, 23, 10.1016/j.toxicon.2018.07.006 · doi:10.1016/j.toxicon.2018.07.006
  199. Dale, 2014, Photobiostimulation reduces edema formation induced in mice by Lys-49 phospholipases A2 isolated from Bothrops moojeni venom, Photochem. Photobiol. Sci., 13, 1561, 10.1039/c4pp00111g · doi:10.1039/c4pp00111g
  200. Campos, 2018, Light emitting diode (LED) therapy reduces local pathological changes induced by Bothrops asper snake venom, Toxicon, 152, 95, 10.1016/j.toxicon.2018.07.029 · DOI

200 of 207 shown

Cited by

See all 96

Metadata

Authors
Gutiérrez, J. M., Albulescu, L.-O., Clare, R. H., Casewell, N. R., Abd El-Aziz, T. M., Escalante, T., & Rucavado, A.
Affiliations
  • Facultad de Microbiología, Instituto Clodomiro Picado, Universidad de Costa Rica, San José 11501, Costa Rica
  • Centre for Snakebite Research & Interventions, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK
  • Zoology Department, Faculty of Science, Minia University, El-Minia 61519, Egypt
Venue
Toxins
Publisher
MDPI AG
Published
2021-06-29
Volume
13
Issue
7
Pages
451
ISSN
2072-6651
Cited by
96
References
6
Language
en
Funders
Vicerrectoría de Investigación, Universidad de Costa Rica (No grant number)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Search for Natural and Synthetic Inhibitors That Would Complement Antivenoms as Therapeutics for Snakebite Envenoming. https://app.cochat.ai/papers/10.3390/toxins13070451
The paper
Gutiérrez, J. M., Albulescu, L.-O., Clare, R. H., Casewell, N. R., Abd El-Aziz, T. M., Escalante, T., & Rucavado, A. (2021). The Search for Natural and Synthetic Inhibitors That Would Complement Antivenoms as Therapeutics for Snakebite Envenoming. Toxins. https://doi.org/10.3390/toxins13070451

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.